Treatment of Cerebral Arteriovenous Malformations With SQUID™ Liquid Embolic Agent

NCT02602990 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-09-20

No results posted yet for this study

Summary

A non-interventional multicentric study for patients with a cerebral AVM for which endovascular treatment is indicated.

Conditions

  • Cerebral Arteriovenous Malformations

Interventions

DEVICE

SQUID™

Sponsors & Collaborators

  • Archer Research

    collaborator INDUSTRY
  • Emboflu

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Belgium
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02602990 on ClinicalTrials.gov